GlassScriptPhysician profile
Jose F Deleon
NPI 1457349524
$9,847.50
in general payments reported to CMS, 2019-2025
25 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $454 · 2021: $423 · 2022: $359 · 2023: $7,200 · 2024: $576 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,599 · Travel and Lodging: $2,229 · Food and Beverage: $1,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,599.00 |
| Travel and Lodging | $2,229.32 |
| Food and Beverage | $1,284.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,786.65 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $1,165.81 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Lupin INC. | $241.83 | 2019-2021 | |
| Vivus LLC | $222.45 | 2019-2024 | Qsymia |
| Astellas Pharma US INC | $217.82 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $191.01 | 2024 | |
| Exeltis, USA INC. | $144.84 | 2020-2024 | Slynd |
| Pfizer INC. | $102.76 | 2022-2025 | |
| Monaghan Medical Corporation | $94.76 | 2024 | Aerochamber, Aeroeclipse, Aerobika |
| Northgate Technologies, INC. | $62.97 | 2024 | Stimsite |
| Hologic Sales and Service, LLC | $61.91 | 2022 | |
| Minerva Surgical, INC | $61.32 | 2021-2023 | |
| Myriad Women'S Health, INC. | $60.58 | 2023 | Myrisk |
| Evofem Biosciences, INC. | $58.20 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $57.72 | 2020-2024 | Gardasil 9, Gardasil |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $51.99 | 2025 | Zurzuvae |
| Novo Nordisk INC | $49.89 | 2019-2024 | |
| Organon LLC | $49.78 | 2024-2025 | Nexplanon |
| Myovant Sciences INC. | $36.95 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $34.13 | 2025 | Myfembree |
| Exact Sciences Corporation | $23.39 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $23.39 | 2025 | Dexcom G6 Transmitter |
| Mayne Pharma Commercial LLC | $20.64 | 2025 | |
| Aspira Women'S Health INC | $14.98 | 2023 | Ova1 |
| Roche Diagnostics Corporation | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Deleon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.